Ever since health officials announced Canada’s first known case of rare, post-vaccination blood clots back in April, scientists have been racing to learn more about what causes the potentially deadly condition — and how to treat it.
Now, a team from McMaster University in Hamilton has published new research-backed recommendations calling on clinicians to use a combination of two treatments: anti-clotting drugs alongside high doses of an intravenous, antibody-based therapy.
The potential effectiveness was outlined in three case studies featuring some of the first Canadian patients who developed post-vaccine blood clots, which was published Wednesday in The New England Journal of Medicine.
The three
This story was originally published on CBC News. To read the rest of this news worthy story, please visit https://www.cbc.ca/news/health/post-vaccine-blood-clots-treatment-1.6059482?cmp=rss.